Literature DB >> 23360641

Antiproliferative effect of pHLIP-amanitin.

Anna Moshnikova1, Valentina Moshnikova, Oleg A Andreev, Yana K Reshetnyak.   

Abstract

Toxins could be effective anticancer drugs, if their selective delivery into cancer cells could be achieved. We have shown that the energy of membrane-associated folding of water-soluble membrane peptides of the pHLIP (pH low insertion peptide) family could be used to move cell-impermeable cargo across the lipid bilayer into the cytoplasm of cancer cells. Here we present the results of a study of pHLIP-mediated cellular delivery of a polar cell-impermeable toxin, α-amanitin, an inhibitor of RNA polymerase II. We show that pHLIP can deliver α-amanitin into cells in a pH-dependent fashion and induce cell death within 48 h. Translocation capability could be tuned by conjugating amanitin to the C-terminus of pHLIP via linkers of different hydrophobicities that could be cleaved in the cytoplasm. pHLIP-SPDP-amanitin, which exhibits 4-5 times higher antiproliferative ability at pH 6 than at pH 7.4, was selected as the best construct. The major mechanism of amanitin delivery is direct translocation (flip) across a membrane by pHLIP and cleavage of the S-S bond in the cytoplasm. The antiproliferative effect was monitored on four different human cancer cell lines. pHLIP-mediated cytoplasmic delivery of amanitin could create great opportunities to use the toxin as a potent pH-selective anticancer agent, which predominantly targets highly proliferative cancer cells at low extracellular pH values.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360641      PMCID: PMC3580847          DOI: 10.1021/bi301647y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  pH-controlled delivery of luminescent europium coated nanoparticles into platelets.

Authors:  Amy Davies; David J Lewis; Stephen P Watson; Steven G Thomas; Zoe Pikramenou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

2.  Modulation of the pHLIP transmembrane helix insertion pathway.

Authors:  Alexander G Karabadzhak; Dhammika Weerakkody; Dayanjali Wijesinghe; Mak S Thakur; Donald M Engelman; Oleg A Andreev; Vladislav S Markin; Yana K Reshetnyak
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

3.  Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP.

Authors:  Yana K Reshetnyak; Lan Yao; Sida Zheng; Sergey Kuznetsov; Donald M Engelman; Oleg A Andreev
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

4.  pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation.

Authors:  Ming An; Dayanjali Wijesinghe; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-03       Impact factor: 11.205

Review 5.  Passive and active drug targeting: drug delivery to tumors as an example.

Authors:  Vladimir P Torchilin
Journal:  Handb Exp Pharmacol       Date:  2010

Review 6.  Ribosomal biosynthesis of the cyclic peptide toxins of Amanita mushrooms.

Authors:  Jonathan D Walton; Heather E Hallen-Adams; Hong Luo
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

7.  Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.

Authors:  Gerhard Moldenhauer; Alexei V Salnikov; Sandra Lüttgau; Ingrid Herr; Jan Anderl; Heinz Faulstich
Journal:  J Natl Cancer Inst       Date:  2012-03-27       Impact factor: 13.506

8.  Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide.

Authors:  Dayanjali Wijesinghe; Donald M Engelman; Oleg A Andreev; Yana K Reshetnyak
Journal:  Biochemistry       Date:  2011-11-04       Impact factor: 3.162

9.  Spatiotemporal activation of caspase-dependent and -independent pathways in staurosporine-induced apoptosis of p53wt and p53mt human cervical carcinoma cells.

Authors:  Magali Nicolier; Anne-Zélie Decrion-Barthod; Sophie Launay; Jean-Luc Prétet; Christiane Mougin
Journal:  Biol Cell       Date:  2009-06-04       Impact factor: 4.458

10.  A novel technology for the imaging of acidic prostate tumors by positron emission tomography.

Authors:  Amy L Vāvere; Gráinne B Biddlecombe; William M Spees; Joel R Garbow; Dayanjali Wijesinghe; Oleg A Andreev; Donald M Engelman; Yana K Reshetnyak; Jason S Lewis
Journal:  Cancer Res       Date:  2009-05-05       Impact factor: 12.701

View more
  30 in total

1.  Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells and Mouse Models.

Authors:  Kelly E Burns; Harvey Hensley; Matthew K Robinson; Damien Thévenin
Journal:  Mol Pharm       Date:  2017-01-13       Impact factor: 4.939

2.  Aggregation Behavior of pHLIP in Aqueous Solution at Low Concentrations: A Fluorescence Study.

Authors:  Bhagyashree D Rao; Hirak Chakraborty; Sandro Keller; Amitabha Chattopadhyay
Journal:  J Fluoresc       Date:  2018-06-29       Impact factor: 2.217

3.  Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.

Authors:  Alexander A Svoronos; Raman Bahal; Mohan C Pereira; Francisco N Barrera; John C Deacon; Marcus Bosenberg; Daniel DiMaio; Peter M Glazer; Donald M Engelman
Journal:  Mol Pharm       Date:  2020-01-13       Impact factor: 4.939

4.  Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.

Authors:  Kelly E Burns; Matthew K Robinson; Damien Thévenin
Journal:  Mol Pharm       Date:  2015-03-13       Impact factor: 4.939

5.  Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.

Authors:  Nerissa Therese Viola-Villegas; Sean D Carlin; Ellen Ackerstaff; Kuntal K Sevak; Vadim Divilov; Inna Serganova; Natalia Kruchevsky; Michael Anderson; Ronald G Blasberg; Oleg A Andreev; Donald M Engelman; Jason A Koutcher; Yana K Reshetnyak; Jason S Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-01       Impact factor: 11.205

6.  Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.

Authors:  Linden C Wyatt; Anna Moshnikova; Troy Crawford; Donald M Engelman; Oleg A Andreev; Yana K Reshetnyak
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

7.  Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.

Authors:  John C Deacon; Donald M Engelman; Francisco N Barrera
Journal:  Arch Biochem Biophys       Date:  2014-11-18       Impact factor: 4.013

Review 8.  Applications of pHLIP Technology for Cancer Imaging and Therapy.

Authors:  Linden C Wyatt; Jason S Lewis; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Trends Biotechnol       Date:  2017-04-21       Impact factor: 19.536

9.  Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.

Authors:  Alanna R Kaplan; Ha Pham; Yanfeng Liu; Stanley Oyaghire; Raman Bahal; Donald M Engelman; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2020-02-25       Impact factor: 5.852

10.  Targeting ion transport in cancer.

Authors:  E Oosterwijk; R J Gillies
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.